51 related articles for article (PubMed ID: 3788606)
21. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
22. The influence of sodium status and furosemide on canine acute amphotericin B nephrotoxicity.
Gerkens JF; Branch RA
J Pharmacol Exp Ther; 1980 Aug; 214(2):306-11. PubMed ID: 7391978
[TBL] [Abstract][Full Text] [Related]
23. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular effects of infused adenosine in man: potentiation by dipyridamole.
Conradson TB; Dixon CM; Clarke B; Barnes PJ
Acta Physiol Scand; 1987 Mar; 129(3):387-91. PubMed ID: 3577821
[TBL] [Abstract][Full Text] [Related]
25. Species differences in renal vascular effects of dipyridamole and in the potentiation of adenosine action by dipyridamole.
Sakai K; Aono J; Haruta K
J Cardiovasc Pharmacol; 1981; 3(3):420-30. PubMed ID: 6168824
[TBL] [Abstract][Full Text] [Related]
26. The influence of furosemide on intrarenal distribution of 2-sulphanilamido-5-methoxypyrimidine in rats with normal and reduced renal parenchyma.
Bohdanecká M; Schück O
Czech Med; 1986; 9(3):157-61. PubMed ID: 3095075
[TBL] [Abstract][Full Text] [Related]
27. Determination of the onset of beta-methyl-digoxin action by potentiation of the adenosine response in guinea pigs.
Fukuda T; Kawakami Y; Furuno K; Araki Y
Acta Med Okayama; 1985 Jun; 39(3):171-7. PubMed ID: 4024991
[TBL] [Abstract][Full Text] [Related]
28. Effects of hydration on gentamicin excretion and renal accumulation in furosemide-treated rats.
Chiu PJ; Long JF
Antimicrob Agents Chemother; 1978 Aug; 14(2):214-7. PubMed ID: 697349
[TBL] [Abstract][Full Text] [Related]
29. Plasma concentration of adenosine during normoxia and moderate hypoxia in humans.
Saito H; Nishimura M; Shinano H; Makita H; Tsujino I; Shibuya E; Sato F; Miyamoto K; Kawakami Y
Am J Respir Crit Care Med; 1999 Mar; 159(3):1014-8. PubMed ID: 10051286
[TBL] [Abstract][Full Text] [Related]
30. Measurement of rat plasma adenosine levels during normoxia and hypoxia.
Phillis JW; O'Regan MH; Perkins LM
Life Sci; 1992; 51(15):PL149-52. PubMed ID: 1528087
[TBL] [Abstract][Full Text] [Related]
31. Oral dipyridamole increases plasma adenosine levels in human beings.
German DC; Kredich NM; Bjornsson TD
Clin Pharmacol Ther; 1989 Jan; 45(1):80-4. PubMed ID: 2910640
[TBL] [Abstract][Full Text] [Related]
32. Dipyridamole inhibition of adenosine metabolism in human blood.
Klabunde RE
Eur J Pharmacol; 1983 Sep; 93(1-2):21-6. PubMed ID: 6628545
[TBL] [Abstract][Full Text] [Related]
33. The effect of dipyridamole on plasma adenosine levels and skin micro-circulation in man.
Sollevi A; Ostergren J; Hjemdahl P; Fredholm BB; Fagrell B
Adv Exp Med Biol; 1984; 165 Pt A():547. PubMed ID: 6720418
[No Abstract] [Full Text] [Related]
34. Adenosine metabolism in dog whole blood: effects of dipyridamole.
Klabunde RE; Althouse DG
Life Sci; 1981 Jun; 28(23):2631-41. PubMed ID: 7266243
[No Abstract] [Full Text] [Related]
35. [The mechanism of intensification of the overacidification of tumors by NAD. The pharmacology of NAD].
von Ardenne M; Reitnauer PG; Hilse H; Oehme P
Pharmazie; 1978 Nov; 33(11):753-9. PubMed ID: 35798
[No Abstract] [Full Text] [Related]
36. Adenosine may regulate the vascular supply and thus the growth and spread of neoplastic tissues: a proposal.
Phillis JW; Wu PH
Gen Pharmacol; 1981; 12(5):309-10. PubMed ID: 7026349
[No Abstract] [Full Text] [Related]
37. Effects of dipyridamole and furosemide on renal function during adenine dinucleotide infusion in rats.
Redlak M; Szczepańska-Konkel M; Stepiński J; Angielski S
Acta Physiol Pol; 1986; 37(1):1-7. PubMed ID: 3788606
[TBL] [Abstract][Full Text] [Related]
38. Renal haemodynamics and natriuretic responses to intravenous administration of diadenosine tetraphosphate (Ap4A) and nicotinamide adenine dinucleotide (NAD) in rat.
Szczepańska-Konkel M; Langner G; Bednarczuk G; Stiepanow-Trzeciak A; Jankowski M; Angielski S
J Physiol Pharmacol; 2003 Jun; 54(2):163-73. PubMed ID: 12832719
[TBL] [Abstract][Full Text] [Related]
39. The renal actions of adenosine.
Kövér G; Tost H
Acta Physiol Hung; 1994; 82(3):215-28. PubMed ID: 7717084
[TBL] [Abstract][Full Text] [Related]
40. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
